Selective roles of MAPKs during the macrophage response to IFN-γ

被引:85
作者
Valledor, Annabel F. [2 ]
Sanchez-Tillo, Ester [1 ]
Arpa, Luis [1 ]
Park, Jin Mo [5 ,6 ]
Caelles, Carme [3 ,4 ]
Lloberas, Jorge [1 ]
Celada, Antonio [1 ]
机构
[1] Inst Biomed Res, Macrophage Biol Grp, Barcelona 08028, Spain
[2] Inst Biomed Res, Sch Biol, Dept Physiol, Nucl Receptors Grp, Barcelona 08028, Spain
[3] Inst Biomed Res, Cell Signaling Grp, Barcelona 08028, Spain
[4] Univ Barcelona, Barcelona, Spain
[5] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA
[6] Harvard Univ, Sch Med, Charlestown, MA 02129 USA
关键词
D O I
10.4049/jimmunol.180.7.4523
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Macrophages perform essential functions in the infection and resolution of inflammation. IFN-gamma is the main endogenous macrophage Th1 type activator. The classical IFN-gamma signaling pathway involves activation of Stat-1. However, IFN-gamma has also the capability to activate members of the MAPK family. In primary bone marrow-derived macrophages, we have observed strong activation of p38 at early time points of IFN-gamma stimulation, whereas weak activation of ERK-1/2 and JNK-1 was detected at a more delayed stage. In parallel, IFN-gamma exerted repressive effects on the expression of a number of MAPK phosphatases. By using selective inhibitors and knockout models, we have explored the contributions of MAPK activation to the macrophage response to IFN-gamma. Our findings indicate that these kinases regulate IFN-gamma-mediated gene expression in a rather selective way: p38 participates mainly in the regulation of the expression of genes required for the innate immune response, including chemokines such as CCLS, CXCL9, and CXCL10; cytokines such as TNF-alpha; and inducible NO synthase, whereas JNK-1 acts on genes involved in Ag presentation, including CIITA and genes encoding MHC class II molecules. Modest effects were observed for ERK-1/2 in these studies. Interestingly, some of the MAPK-dependent changes in gene expression observed in these studies are based on posttranscriptional regulation of mRNA stability.
引用
收藏
页码:4523 / 4529
页数:7
相关论文
共 39 条
[1]   Cellular responses to interferon-gamma [J].
Boehm, U ;
Klamp, T ;
Groot, M ;
Howard, JC .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :749-795
[2]   Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway [J].
Caelles, C ;
González-Sancho, JM ;
Muñoz, A .
GENES & DEVELOPMENT, 1997, 11 (24) :3351-3364
[3]   EVIDENCE FOR A GAMMA-INTERFERON RECEPTOR THAT REGULATES MACROPHAGE TUMORICIDAL ACTIVITY [J].
CELADA, A ;
GRAY, PW ;
RINDERKNECHT, E ;
SCHREIBER, RD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (01) :55-74
[4]   The transcription factor PU.1 is involved in macrophage proliferation [J].
Celada, A ;
Borras, FE ;
Soler, C ;
Lloberas, J ;
Klemsz, M ;
vanBeveren, C ;
McKercher, S ;
Maki, RA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (01) :61-69
[5]   MACROPHAGE ACTIVATION REVISITED [J].
CELADA, A ;
NATHAN, C .
IMMUNOLOGY TODAY, 1994, 15 (03) :100-102
[6]   Conditional gene targeting in macrophages and granulocytes using LysMcre mice [J].
Clausen, BE ;
Burkhardt, C ;
Reith, W ;
Renkawitz, R ;
Förster, I .
TRANSGENIC RESEARCH, 1999, 8 (04) :265-277
[7]   Defective T cell differentiation in the absence of Jnk1 [J].
Dong, C ;
Yang, DD ;
Wysk, M ;
Whitmarsh, AJ ;
Davis, RJ ;
Flavell, RA .
SCIENCE, 1998, 282 (5396) :2092-2095
[8]   Targeted disruption of the mouse STAT1 results in compromised innate immunity to viral disease [J].
Durbin, JE ;
Hackenmiller, R ;
Simon, MC ;
Levy, DE .
CELL, 1996, 84 (03) :443-450
[9]   Biologic consequences of Stat1-independent IFN signaling [J].
Gil, MP ;
Bohn, E ;
O'Guin, AK ;
Ramana, CV ;
Levine, B ;
Stark, GR ;
Virgin, HW ;
Schreiber, RD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (12) :6680-6685
[10]   p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons [J].
Goh, KC ;
Haque, SJ ;
Williams, BRG .
EMBO JOURNAL, 1999, 18 (20) :5601-5608